Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Epirubicin × 30 days × Clear all

Sponsor

Conditions

Resectable HER2-positive Breast Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

ribociclib 1 exemestane 1 Leuprolide 1 Letrozole 1 Immunotherapy 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡